IRS4 and neoplasm: Indeed, we found that co-expression of Irs4 and ErbB2 in mammary epithelial cells synergistically accelerated tumour growth due to their activity in complementary oncogenic pathways: the PI3K/AKT and MAPK/ERK pathways, respectively (Fig. 8e).